These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5628854)

  • 1. Effect of diluents on blood clot lysis.
    Gallimore MJ
    J Clin Pathol; 1967 May; 20(3):234-8. PubMed ID: 5628854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium acetate buffer: a diluent of choice in the clot lysis time technique.
    Chohan IS; Vermylen J; Singh I; Balakrishnan K; Verstraete M
    Thromb Diath Haemorrh; 1975 Apr; 33(2):226-9. PubMed ID: 1138420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic activity at high altitude and sodium acetate buffer.
    Chohan IS; Singh I; Balakrihsnan K
    Thromb Diath Haemorrh; 1974 Sep; 32(1):65-70. PubMed ID: 4454046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
    Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
    Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
    J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
    Rusak T; Piszcz J; Misztal T; Brańska-Januszewska J; Tomasiak M
    Thromb Res; 2014 Jul; 134(1):192-8. PubMed ID: 24824295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinolysis: kinetics of the lysis of a fibrin clot].
    Daver J; Edmond E; Panak E; Ricoeur M
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):333-42. PubMed ID: 4246032
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.
    Gilliam JM; Berkus V; Taylor FB
    Am J Pathol; 1979 Jul; 96(1):35-50. PubMed ID: 464023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
    Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro modification of the dilute blood clot lysis time for determining fibrinolytic activity.
    Spittle CR; Lansdown NM; Hawkey CM
    J Clin Pathol; 1968 Nov; 21(6):780-1. PubMed ID: 5717554
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.
    Saadah NH; van der Meer PF; Brinkman HJM; de Korte D; Bontekoe IJ; Korsten HH; Middelburg RA; van der Bom JG; Schipperus MR
    Transfusion; 2017 Oct; 57(10):2381-2389. PubMed ID: 28727139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.